The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators On-Demand Webinar The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…Certara2026 年 5 月 26 日
Simcyp Focused Workshop: DDI (Predicting and evaluating complex DDIs) Japan Live Events Simcyp 专题研讨会:DDI(复杂药物相互作用的预测与评估)日本 Certara2026 年 5 月 20 日
Simcyp Focus Group Workshop: Biopharmaceutics Applications of PBPK Modelling – Japan Live Events Simcyp 线下研讨会:PBPK 建模在生物药剂学中的应用 — 日本 Certara2026 年 5 月 19 日
How to Leverage PBPK Modeling and Simulation in Drug Research and Development Guide 如何在药物研发中运用 PBPK 建模与模拟 Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…Certara2026 年 5 月 12 日
Minimize risk when preparing for hepatic impairment studies Webinar Minimize risk when preparing for hepatic impairment studies Certara2026 年 5 月 12 日
PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials Press Coverage PBPK Modeling in Pregnancy: Improving Drug Dosing Without Clinical Trials The FDA is shifting toward approving drugs based on a single pivotal trial supported by…Certara2026 年 5 月 12 日
The one-trial era: what the FDA’s shift signals for the future of drug development Press Coverage The one-trial era: what the FDA’s shift signals for the future of drug development The FDA is shifting toward approving drugs based on a single pivotal trial supported by…Certara2026 年 5 月 6 日
How pharma can transition to non-animal studies for investigational drugs Blog 如何实现药品研发中的动物实验向非动物实验的转型 Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…Certara2026 年 5 月 5 日
From models to impact: What QSPC 2026 revealed about the future of drug development Blog From models to impact: What QSPC 2026 revealed about the future of drug development Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…Certara2026 年 4 月 28 日
Top 10 benefits of Simcyp® Simulator for drug development Blog Top 10 benefits of Simcyp® Simulator for drug development JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026 年 4 月 23 日 Physiologically based pharmacokinetic (PBPK) modeling has evolved from an emerging methodology…Certara2026 年 4 月 23 日